chr6-69701547-T-TA
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BA1
The NM_018368.4(LMBRD1):c.981-3dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00693 in 1,541,856 control chromosomes in the GnomAD database, including 238 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0071 ( 22 hom., cov: 32)
Exomes 𝑓: 0.0069 ( 216 hom. )
Consequence
LMBRD1
NM_018368.4 splice_region, intron
NM_018368.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.138
Genes affected
LMBRD1 (HGNC:23038): (LMBR1 domain containing 1) This gene encodes a lysosomal membrane protein that may be involved in the transport and metabolism of cobalamin. This protein also interacts with the large form of the hepatitis delta antigen and may be required for the nucleocytoplasmic shuttling of the hepatitis delta virus. Mutations in this gene are associated with the vitamin B12 metabolism disorder termed, homocystinuria-megaloblastic anemia complementation type F.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 6-69701547-T-TA is Benign according to our data. Variant chr6-69701547-T-TA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 225404.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1, Benign=3}.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0727 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMBRD1 | NM_018368.4 | c.981-3dupT | splice_region_variant, intron_variant | ENST00000649934.3 | NP_060838.3 | |||
LMBRD1 | NM_001363722.2 | c.762-3dupT | splice_region_variant, intron_variant | NP_001350651.1 | ||||
LMBRD1 | NM_001367271.1 | c.762-3dupT | splice_region_variant, intron_variant | NP_001354200.1 | ||||
LMBRD1 | NM_001367272.1 | c.762-3dupT | splice_region_variant, intron_variant | NP_001354201.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMBRD1 | ENST00000649934.3 | c.981-3dupT | splice_region_variant, intron_variant | NM_018368.4 | ENSP00000497690.1 |
Frequencies
GnomAD3 genomes AF: 0.00709 AC: 1074AN: 151468Hom.: 22 Cov.: 32
GnomAD3 genomes
AF:
AC:
1074
AN:
151468
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0121 AC: 2781AN: 229438Hom.: 82 AF XY: 0.0124 AC XY: 1545AN XY: 124620
GnomAD3 exomes
AF:
AC:
2781
AN:
229438
Hom.:
AF XY:
AC XY:
1545
AN XY:
124620
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00691 AC: 9611AN: 1390270Hom.: 216 Cov.: 23 AF XY: 0.00704 AC XY: 4895AN XY: 694824
GnomAD4 exome
AF:
AC:
9611
AN:
1390270
Hom.:
Cov.:
23
AF XY:
AC XY:
4895
AN XY:
694824
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00708 AC: 1073AN: 151586Hom.: 22 Cov.: 32 AF XY: 0.00922 AC XY: 683AN XY: 74080
GnomAD4 genome
AF:
AC:
1073
AN:
151586
Hom.:
Cov.:
32
AF XY:
AC XY:
683
AN XY:
74080
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
133
AN:
3458
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Methylmalonic aciduria and homocystinuria type cblF Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 21, 2023 | - - |
Donnai-Barrow syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | reference population | Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center | Mar 18, 2016 | - - |
Disorders of Intracellular Cobalamin Metabolism Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 17, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at